(Q39460393)

12 September 2017

title

Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance? (English)

1 reference

12 September 2017

1 reference

1 reference

2

1 reference

12 September 2017

Agnieszka Dreier

1

1 reference

12 September 2017

Anand Goswami

series ordinal

3

1 reference

12 September 2017

Joachim Weis

series ordinal

4

1 reference

12 September 2017

publication date

11 October 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

33

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

85-94

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-011-0248-4

12 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Autocrine, paracrine and juxtacrine signaling by EGFR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Comparing antibody and small-molecule therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Human squamous cell lung cancers express increased epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Variants of 3T3 cells lacking mitogenic response to epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

The ErbB receptor family: a therapeutic target for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: a potential mechanism of EGFR-driven antagonism of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Mitochondrially localized EGFR is independent of its endocytosis and associates with cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

ERK2 signalling from internalised epidermal growth factor receptor in broken A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Internalization of the epidermal growth factor receptor: role in signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0248-4

Monoclonal antibody therapy of cancer

21 January 2018

1 reference

12 December 2020

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

12 December 2020

Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements

1 reference

12 December 2020

Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.

1 reference

12 December 2020

Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.

1 reference

12 December 2020

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors

1 reference

12 December 2020

Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.

1 reference

12 December 2020

Expression of epidermal growth factor receptors in human brain tumors

1 reference

12 December 2020

A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis

1 reference

12 December 2020

EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.

1 reference

12 December 2020

Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III.

1 reference

12 December 2020

10.1007/S13277-011-0248-4

Identifiers

DOI

1 reference

12 September 2017

1 reference